Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
03/2003
03/05/2003EP1286673A2 Ligands of integrin receptors
03/05/2003EP1286670A2 Use of therapeutic benzamide derivatives
03/05/2003EP1115719B1 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/05/2003EP1054859A4 Processes and intermediates useful to make antifolates
03/05/2003EP0853610B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/05/2003CN1400974A Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors
03/05/2003CN1400969A Fused imidazolium derivatives
03/05/2003CN1102580C Arylethenesulfonamide derivatives and drug composition containing the same
03/05/2003CN1102573C Aryl or heteroaryl substd, 3,4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs having bioactivity of visual pigmentoid
03/04/2003US6528655 Aromatic derivatives with HIV integrase inhibitory properties
03/04/2003US6528627 Bridged aromatic substituted amine ligands with donor atoms
03/04/2003US6528532 Benzenesulfonamide group
03/04/2003US6528528 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
03/04/2003US6528510 HIV protease inhibitors
03/04/2003US6528232 Chemically amplified photoresist composition using the novel sulfonium salt compound as the photoacid generator
03/04/2003CA2218913C Substituted oximes, hydrazones and olefins as neurokinin antagonists
02/2003
02/27/2003WO2003016430A1 Light-emitting fluorene-based copolymers, el devices comprising the same and method of synthesis thereof.
02/27/2003WO2003016270A2 Selective estrogen receptor modulators
02/27/2003WO2003015769A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments
02/27/2003WO2003000181A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes
02/27/2003WO2002100851A3 Thiophene derivatives as antiviral agents for flavivirus infection
02/27/2003WO2002089740A3 Sulfonamides
02/27/2003WO2002085301A3 Indole, azaindole and related heterocyclic amidopiperazine derivatives
02/27/2003US20030040545 (R)-Chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity
02/27/2003US20030040540 Bromonitrothienyldioxanes
02/27/2003US20030040538 Novel substituted tricyclic compounds
02/27/2003US20030040483 Compounds with growth hormone releasing properties
02/27/2003CA2457037A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments
02/26/2003EP1285902A1 Method for labeling with tritium
02/26/2003EP1064276B1 PROCESS FOR SYNTHESIZING SUBSTITUTED 2-BENZO b] THIOPHENE CARBOXYLIC ACIDS AND SALTS THEREOF
02/26/2003EP0920431B1 Thienopyrimidines
02/26/2003EP0885187B1 Diphenylethers, process and intermediate products for their preparation, and their use
02/26/2003CN1102142C Novel N-acyl sulphonamides, novel mixtures of herbicides and antidotes and their use
02/25/2003US6525099 N-substituted sulfonamide derivatives
02/25/2003US6525085 Diaryl-enynes
02/25/2003US6525072 Prevention and treatment of cellular disorders such as cancer
02/25/2003US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists
02/25/2003US6525042 Sulfonyl derivatives
02/25/2003US6525036 Compounds and compositions as protease inhibitors
02/21/2003WO2002020462A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
02/21/2003CA2419722A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
02/20/2003WO2003014107A1 Process for the preparation of heterocyclic pentalene derivatives
02/20/2003WO2003014106A1 METHOD FOR PREPARING OPTICALLY ACTIVE α-SUBSTITUTED HETEROCYCLICCARBOXYLIC ACID ESTER
02/20/2003WO2003014072A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands
02/20/2003WO2003014064A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
02/20/2003WO2003013723A1 Palladium catalysts
02/20/2003WO2003013510A1 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
02/20/2003WO2003013506A1 Sulphonamides for control of beta-amyloid production
02/20/2003WO2003013484A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
02/20/2003WO2002068399B1 Aryl carbamate derivatives, preparation and use thereof
02/20/2003WO2002049993A3 High affinity small molecule c5a receptor modulators
02/20/2003WO2002030882A9 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
02/20/2003WO2002024635A3 Aminoalcohol derivatives
02/20/2003US20030036612 Containing a ligand such as (3-methyl-4-trimethylsilyl-1-cyclopentadienyl)-7-(2,5-dimethyl -cyclopenta(1,2-b:4,3-b')-dithiophene)dimethylsilane
02/20/2003US20030035332 The preparation and use of ortho-sulfonamido arylhydroxamic acids as matrix metalloproteinase inhibitors
02/20/2003CA2457814A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands
02/20/2003CA2455754A1 Amine derivatives
02/19/2003EP1284265A1 Benzothiophene derivatives and medicinal use thereof
02/19/2003EP1284257A2 Difluoromethylene aromatic ethers and their use as inhibitors of the glycine type-1 transporter
02/19/2003EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
02/19/2003EP1144360A4 A method for the synthesis of compounds of formula 1 and derivatives thereof
02/19/2003EP1020179A4 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
02/19/2003EP0799218B1 Diaryl-2-(5h)-furanones as cox-2 inhibitors
02/19/2003EP0690867B1 Taxanes having furyl or thienyl substituted side-chain
02/19/2003CN1398252A Dehydroamino acids compounds
02/19/2003CN1397551A N-([1,2,4]triazoleo azine group) benzene sulfonamide and pyridine sulfamide compound and their use as herbicide
02/19/2003CN1397550A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them
02/18/2003US6521667 Calcilytic compounds
02/18/2003US6521666 Inhibitors of α4 mediated cell adhesion
02/18/2003US6521624 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
02/18/2003US6521622 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
02/18/2003US6521607 (R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
02/18/2003CA2420042A1 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
02/16/2003CA2397698A1 Difluoromethylene aromatic ethers as inhibitors of glycine transport
02/13/2003WO2003011872A1 Platelet adp receptor inhibitors
02/13/2003WO2003011851A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
02/13/2003WO2003011812A1 NOVEL AMINE DERIVATIVE HAVING HUMAN β-TRYPTASE INHIBITORY ACTIVITY AND DRUGS CONTAINING THE SAME
02/13/2003WO2003011807A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
02/13/2003WO2003011290A1 Methods for inhibiting or reversing tau filament formation polymerization
02/13/2003WO2002033110A3 PRODUCTION OF α-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM
02/13/2003US20030032779 Estrogen receptor ligands
02/13/2003US20030032671 Propionic acid derivatives
02/13/2003US20030032665 Method of inhibiting matrix metalloproteinases
02/13/2003US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
02/13/2003CA2468925A1 Platelet adp receptor inhibitors
02/13/2003CA2456096A1 Novel amine derivative having human .beta.-tryptase inhibitory activity and medecine containing the same
02/13/2003CA2455969A1 Methods for inhibiting or reversing tau filament formation polymerization
02/13/2003CA2452665A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
02/13/2003CA2449804A1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
02/12/2003EP1283521A2 Optical information recording medium and novel immonium compound
02/12/2003EP1282614A1 Hydroxamic acid derivatives
02/12/2003EP1282595A1 Novel phenyl-propargylether derivatives
02/12/2003EP1282415A2 Compounds and methods for regulating bacterial growth and pathogenesis
02/12/2003CN1396819A Novel coupler for use in oxidative hair dyeing
02/12/2003CN1396163A Thiophen sulfuryl compound
02/12/2003CN1101374C Synthesis of alpha-chloro or fluoro ketones
02/11/2003US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
02/11/2003US6518283 Squaric acid derivatives
02/11/2003US6518222 N-([1,2,4] triazoloazinyl) thiophenesulfonamide compounds and their use as herbicides
02/11/2003CA2041135C Method for the photochemical isomerisation of organic compounds under the influence of a photosensitizer